Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney Sells 11,152 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 11,152 shares of the business’s stock in a transaction dated Thursday, March 27th. The stock was sold at an average price of $17.89, for a total value of $199,509.28. Following the completion of the sale, the president now directly owns 2,362,899 shares of the company’s stock, valued at $42,272,263.11. This represents a 0.47 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.40, for a total value of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.99, for a total transaction of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total value of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $13.61, for a total value of $408,300.00.

Alignment Healthcare Price Performance

NASDAQ:ALHC traded up $0.17 during mid-day trading on Friday, hitting $18.30. The company’s stock had a trading volume of 1,599,660 shares, compared to its average volume of 1,491,362. The company has a market capitalization of $3.51 billion, a price-to-earnings ratio of -23.77 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. Alignment Healthcare, Inc. has a fifty-two week low of $4.46 and a fifty-two week high of $18.60. The stock has a fifty day moving average of $15.28 and a 200-day moving average of $12.97.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on ALHC shares. Barclays raised their target price on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Bank of America increased their price target on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. Stifel Nicolaus raised their price target on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Finally, Stephens reaffirmed an “overweight” rating and set a $17.00 price objective on shares of Alignment Healthcare in a research report on Monday, February 24th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $14.83.

Institutional Investors Weigh In On Alignment Healthcare

Several large investors have recently modified their holdings of the stock. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Alignment Healthcare in the 3rd quarter valued at $131,000. Intech Investment Management LLC bought a new position in shares of Alignment Healthcare during the third quarter valued at $315,000. Charles Schwab Investment Management Inc. boosted its stake in shares of Alignment Healthcare by 1.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 839,695 shares of the company’s stock valued at $9,925,000 after purchasing an additional 13,865 shares in the last quarter. Algert Global LLC grew its holdings in shares of Alignment Healthcare by 44.8% in the 3rd quarter. Algert Global LLC now owns 80,903 shares of the company’s stock worth $956,000 after purchasing an additional 25,050 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its position in shares of Alignment Healthcare by 132.2% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 128,933 shares of the company’s stock worth $1,524,000 after purchasing an additional 73,402 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.